ExploreWatchlistsPricing
  1. JP-listed companies
  2. TOWA PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Short-term debt

TOWA PHARMACEUTICAL CO.,LTD. (4553)

Market cap
¥220.2B
P/E ratio
11.9x
Towa Pharmaceutical manufactures and sells generic drugs to hospitals and distributors in Japan, Europe, and North America through its own facilities and subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndShort-term debt (Million JPY)YoY (%)
Mar 31, 20254,699+51.00%
Mar 31, 20243,112-15.37%
Mar 31, 20233,677-92.55%
Mar 31, 202249,335+4340.59%
Mar 31, 20211,111-94.80%
Mar 31, 202021,368+2413.88%
Mar 31, 2019850+0.00%
Mar 31, 2018850-51.15%
Mar 31, 20171,740+0.00%
Mar 31, 20161,740+16.78%
Mar 31, 20151,490

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat